Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Saved in:
| Title: | Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole. |
|---|---|
| Authors: | Chapman JW; Canadian Cancer Trials Group Queen's University, 11 Dayman Court, Kitchener, ON, N2M 3A1, Canada. jachapma@aol.com., Bayani J; Ontario Institute for Cancer Research, Toronto, Canada.; University of Toronto, Toronto, Canada., SenGupta S; University of Toronto, Toronto, Canada.; North York General Hospital, Toronto, Canada., Bartlett JMS; University of Edinburgh, Edinburgh, UK., Piper T; University of Edinburgh, Edinburgh, UK., Quintayo MA; Ontario Institute for Cancer Research, Toronto, Canada., Virk S; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Goss PE; Harvard University, Boston, MA, USA., Ingle JN; Mayo Clinic, Rochester, MN, USA., Ellis MJ; Guardant Health, Palo Alta, CA, USA., Sledge GW; Caris Life Sciences, Irving, TX, USA., Budd GT; Cleveland Clinic, Cleveland, OH, USA., Rabaglio M; Inselspital Bern, Bern, Switzerland., Ansari RH; Indiana School of Medicine, South Bend, IN, USA., Tozer R; McMaster University, Hamilton, Canada., D'Souza DP; London Regional Health Science Centre, London, Canada., Chalchal H; Alan Blair Cancer Center, Regina, Canada., Spadafora S; Algoma Regional Cancer Centre, Sault Ste Marie, Canada., Stearns V; Weill Cornell Medicine, New York, NY, USA., Perez EA; Mayo Clinic, Redwood City, CA, USA., Gelmon KA; University of British Columbia, Vancouver, Canada., Whelan TJ; McMaster University, Hamilton, Canada., Elliott C; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Shepherd LE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Chen BE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Taylor KJ; University of Edinburgh, Edinburgh, UK. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Aug; Vol. 213 (1), pp. 51-61. Date of Electronic Publication: 2025 Jun 23. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40549110 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chapman+JW%22">Chapman JW</searchLink>; Canadian Cancer Trials Group Queen's University, 11 Dayman Court, Kitchener, ON, N2M 3A1, Canada. jachapma@aol.com.<br /><searchLink fieldCode="AU" term="%22Bayani+J%22">Bayani J</searchLink>; Ontario Institute for Cancer Research, Toronto, Canada.; University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22SenGupta+S%22">SenGupta S</searchLink>; University of Toronto, Toronto, Canada.; North York General Hospital, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Bartlett+JMS%22">Bartlett JMS</searchLink>; University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Piper+T%22">Piper T</searchLink>; University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Quintayo+MA%22">Quintayo MA</searchLink>; Ontario Institute for Cancer Research, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Virk+S%22">Virk S</searchLink>; Canadian Cancer Trials Group Queen's University, Kingston, Canada.<br /><searchLink fieldCode="AU" term="%22Goss+PE%22">Goss PE</searchLink>; Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ingle+JN%22">Ingle JN</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+MJ%22">Ellis MJ</searchLink>; Guardant Health, Palo Alta, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sledge+GW%22">Sledge GW</searchLink>; Caris Life Sciences, Irving, TX, USA.<br /><searchLink fieldCode="AU" term="%22Budd+GT%22">Budd GT</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Rabaglio+M%22">Rabaglio M</searchLink>; Inselspital Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ansari+RH%22">Ansari RH</searchLink>; Indiana School of Medicine, South Bend, IN, USA.<br /><searchLink fieldCode="AU" term="%22Tozer+R%22">Tozer R</searchLink>; McMaster University, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22D'Souza+DP%22">D'Souza DP</searchLink>; London Regional Health Science Centre, London, Canada.<br /><searchLink fieldCode="AU" term="%22Chalchal+H%22">Chalchal H</searchLink>; Alan Blair Cancer Center, Regina, Canada.<br /><searchLink fieldCode="AU" term="%22Spadafora+S%22">Spadafora S</searchLink>; Algoma Regional Cancer Centre, Sault Ste Marie, Canada.<br /><searchLink fieldCode="AU" term="%22Stearns+V%22">Stearns V</searchLink>; Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Perez+EA%22">Perez EA</searchLink>; Mayo Clinic, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gelmon+KA%22">Gelmon KA</searchLink>; University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Whelan+TJ%22">Whelan TJ</searchLink>; McMaster University, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22Elliott+C%22">Elliott C</searchLink>; Canadian Cancer Trials Group Queen's University, Kingston, Canada.<br /><searchLink fieldCode="AU" term="%22Shepherd+LE%22">Shepherd LE</searchLink>; Canadian Cancer Trials Group Queen's University, Kingston, Canada.<br /><searchLink fieldCode="AU" term="%22Chen+BE%22">Chen BE</searchLink>; Canadian Cancer Trials Group Queen's University, Kingston, Canada.<br /><searchLink fieldCode="AU" term="%22Taylor+KJ%22">Taylor KJ</searchLink>; University of Edinburgh, Edinburgh, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Aug; Vol. 213 (1), pp. 51-61. <i>Date of Electronic Publication: </i>2025 Jun 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40549110 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-025-07749-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 51 Titles: – TitleFull: Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chapman JW – PersonEntity: Name: NameFull: Bayani J – PersonEntity: Name: NameFull: SenGupta S – PersonEntity: Name: NameFull: Bartlett JMS – PersonEntity: Name: NameFull: Piper T – PersonEntity: Name: NameFull: Quintayo MA – PersonEntity: Name: NameFull: Virk S – PersonEntity: Name: NameFull: Goss PE – PersonEntity: Name: NameFull: Ingle JN – PersonEntity: Name: NameFull: Ellis MJ – PersonEntity: Name: NameFull: Sledge GW – PersonEntity: Name: NameFull: Budd GT – PersonEntity: Name: NameFull: Rabaglio M – PersonEntity: Name: NameFull: Ansari RH – PersonEntity: Name: NameFull: Tozer R – PersonEntity: Name: NameFull: D'Souza DP – PersonEntity: Name: NameFull: Chalchal H – PersonEntity: Name: NameFull: Spadafora S – PersonEntity: Name: NameFull: Stearns V – PersonEntity: Name: NameFull: Perez EA – PersonEntity: Name: NameFull: Gelmon KA – PersonEntity: Name: NameFull: Whelan TJ – PersonEntity: Name: NameFull: Elliott C – PersonEntity: Name: NameFull: Shepherd LE – PersonEntity: Name: NameFull: Chen BE – PersonEntity: Name: NameFull: Taylor KJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 213 – Type: issue Value: 1 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |